DHI SIGNAL · FILING RESEARCH

TER Teradyne

Queued for filing review — no Filing Score exists before its 10-K is processed, and no number is shown that the pipeline has not computed. The business-quality screen and the statement series below are deterministic reads of the filed XBRL.

Business quality — Buffett/Munger screen DETERMINISTIC · COMPUTED FROM THE STATEMENTS · NOT A SCORE

MeasureLatestReading
Return on equity19.7%strong
Share count, year-end-3.5%shrinking
Debt to equity0.07low
FCF consistency, 5yrpositive 5 of 5consistent
Margin stabilitypre-tax margin 20.5%cyclical

Statement series EACH OPENS ITS OWN FIVE-YEAR PAGE

MeasureLatestYear
Revenue$3.2BFY2025
Net income$554MFY2025
Operating cash flow$674MFY2025
Free cash flow$450MFY2025
Capital expenditure$224MFY2025
Cash & equivalents$294MFY2025
Total assets$4.2BFY2025
Shareholders' equity$2.8BFY2025
Total debt$0MFY2014
Return on equity19.7%FY2025
Days sales outstanding90.0 daysFY2025

Not investment advice. Scores grade filings, not companies, and exist only for filings actually reviewed; this name carries no number until then.